Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
نویسندگان
چکیده
OBJECTIVE To examine whether impaired glucose tolerance and raised Lp(a) lipoprotein concentrations are associated in subjects with coronary artery disease. DESIGN Study of two subject populations, one with and one without symptomatic coronary artery disease. Case-control analysis of patients with impaired glucose tolerance and normal glucose tolerance performed in each subject population independently. SETTING A general practice and a hospital ward in Newcastle upon Tyne. SUBJECTS 517 apparently healthy subjects, 13 with impaired glucose tolerance, and 245 patients who had undergone coronary artery bypass graft surgery 12 months before, 51 with impaired glucose tolerance. MAIN OUTCOME MEASURES Serum Lp(a) lipoprotein concentration, plasma glucose concentration before and after oral challenge with 75 g glucose monohydrate, and Lp(a) lipoprotein isoforms. RESULTS In both the asymptomatic subjects and the subjects with coronary artery disease there was no significant difference between subjects with impaired glucose tolerance and subjects with normal and body mass index in serum Lp(a) lipoprotein concentrations (geometric mean 61 (geometric SD 4) mg/l v 83 (5) mg/l for asymptomatic subjects, 175 (3) v 197 (2) for subjects with heart disease), nor was there any difference in the proportion of subjects who had Lp(a) lipoprotein concentrations > 300 mg/l (31% v 23% for asymptomatic subjects, 37% v 37% for subjects with heart disease). For both subject groups there was no significant correlation between Lp(a) lipoprotein concentration and plasma glucose concentration after a glucose tolerance test, nor did Lp(a) lipoprotein concentration vary by quintile of glucose concentration after the test. Examination of Lp(a) lipoprotein isoforms in the subjects with coronary artery disease revealed an inverse relation between isoform size and plasma Lp(a) lipoprotein concentration, but there was no evidence that impaired glucose tolerance was associated with particular Lp(a) lipoprotein isoforms. CONCLUSION Raised Lp(a) lipoprotein concentrations are not responsible for the association between impaired glucose tolerance and coronary artery disease.
منابع مشابه
Prevalence of Rose Questionnaire Angina and its Association with Coronary Heart Disease Risk Factors in Tehran, IR.Iran
Background: Rose questionnaire is a standard mean for diagnosing angina pectoris in epidemiological study. The present study was done to determine the prevalence of angina pectoris according to Rose questionnaire for chest pain, and to investigate the association of angina with several coronary hearh disease risk factors in Tehran urban population (district-13) during 1999 to 2000. Methods: 60...
متن کاملIncreased incidence of coronary disease in people with impaired glucose tolerance: link with increased lipoprotein(a) concentrations?
BMJ 1992;304:1610-1 Plasma concentrations of lipoprotein(a) (Lp(a)), a variant of low density lipoprotein, are determined largely genetically.' A recent review described Lp(a) as "emerging as a major determinant of coronary heart disease."' Impaired glucose tolerance affects around 10% of the population and is associated with an increased likelihood of developing both non-insulin dependent diab...
متن کاملAssociation of androgenetic alopecia and hyperlipidemia
Background an objective: Several studies have indicated that vertex type androgenetic alopecia have a higher-than-normal risk for coronary heart disease but few studies focused on lipid profiles which are important in the pathogenesis of coronary heart disease. This study was designed to investigate the relation between vertex type androgenetic alopecia (Grade III and higher according to ...
متن کاملبررسی میزان لیپوپروتئین – آ در پلاسمای مبتلایان به دیابت نوع II
Introduction: Lipoprotein (a) is a particle rich in cholesterol in human plasma and it is known as an independent risk factor for coronary artery disease. In addition to genetic background, other factors such as diabetes affect the plasma concentration of this lipoprotein as a risk factor. The aim of this study was evaluation and comparison of plasma concentration of Lp(a) in type II diabetics ...
متن کاملThe impact of omega-3 supplementation on indices of body composition, lipoprotein and Follistatin-Like 1 circulating level in men with coronary heart disease: A randomized double-blind placebo controlled clinical trial
Background and purpose: Follistatin is a cytokine secreted from the Myocardium, which play a protective role against cardiovascular diseases. The aim of this study was to investigate the effect of omega-3 fatty acids as secondary preventive of cardiovascular disease on indices of body composition, lipoprotein and follistatin-like1protein (FSTL1) circulating level in patients with coronary arter...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- BMJ
دوره 307 6908 شماره
صفحات -
تاریخ انتشار 1993